Navigation Links
Successful lab tests on a potential vaccine for heroin addiction
Date:7/20/2011

Scientists are reporting development and successful initial laboratory tests on the key ingredient for a much-needed vaccine to help individuals addicted to heroin abstain from the illicit drug. Their study appears in ACS' Journal of Medicinal Chemistry.

Kim D. Janda and colleagues note that heroin use cost the United States more than $22 billion in 1996 annually due to medical and law enforcement expenses and productivity loss. Although behavioral therapy and certain medicines help heroin-addicted patients, many experience relapse, lack access to treatment, or develop unwanted side effects from the treatments themselves. To overcome these challenges, the researchers made and tested a new vaccine formulation that might serve as an additional tool in helping addicts maintain abstinence. Janda's team previously reported development of vaccines for cocaine, methamphetamine, and nicotine.

Thus with laboratory rats that were given the vaccine they showed less willingness to self-administer heroin and other signs of its effectiveness. The report explains why the potential new vaccine is an improvement over previous experimental vaccines. "In conclusion, a vaccine for heroin addiction could prove to be a useful tool for combating heroin addiction, wherein it exploits a motivated recovering addict's own immune system to blunt heroin's psychoactive effects in the case of relapse," the researchers say.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
2. Montana Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
3. Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
4. Short-term radiation therapy successful on breast cancer
5. New Successful Treatment Improves Walking Post Stroke
6. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
7. Two Surgical Methods Equally Successful for Prostate Cancer
8. Successful treatment of periodontal disease lowered preterm birth incidences
9. Tommy John elbow reconstruction 95 percent successful with grown teen pitchers, study says
10. BMI of Texas Hosts Successful 2009 Walk from Obesity
11. 2010 What's Next Boomer Business Summit Provides the Blueprint for Successfully Marketing to Baby Boomers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at ... and joint health in horses at the immunologic level. , The scientifically-developed Flexadin ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the ... Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than ... marketer in the last 25 years. , Now, due to changes in the broadcast ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology: